Venus Concept Inc
NASDAQ:VERO
Venus Concept Inc
NASDAQ:VERO
Price:
0.67 USD
-3.57%
Market Closed
Updated:
May 4, 2024
Section:
Relative Value
The Relative Value of one
VERO
stock under the Base Case scenario is
15.45
USD.
Compared to the current market price of 0.67 USD,
Venus Concept Inc
is
Undervalued by 96%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VERO
Relative Value
Base Case
15.45
USD
Undervaluation 96%
Valuation Multiples
Multiples Across Competitors
VERO Competitors Multiples
Venus Concept Inc Competitors
Venus Concept Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Venus Concept Inc
NASDAQ:VERO
|
4.3m USD | 0.1 | -0.1 | -2.9 | -2.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.5B USD | 4.6 | 32.6 | 19.2 | 28.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.1B USD | 18.5 | 68 | 55.8 | 69.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
124.8B USD | 6 | 37.1 | 24.1 | 29.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.5B USD | 3.4 | 25.8 | 13.8 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.2B USD | 7.2 | 60.2 | 30.7 | 45.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.7B USD | 3.5 | 55.6 | 18.6 | 39.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.9B EUR | 2.7 | 38.1 | 18.3 | 30.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.6B USD | 8.4 | 36.5 | 26.5 | 28.7 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.9B USD | 13.4 | 79.6 | 59.5 | 77.4 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
